Dita Demirtas

509 total citations
16 papers, 328 citations indexed

About

Dita Demirtas is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Dita Demirtas has authored 16 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Dita Demirtas's work include Chronic Lymphocytic Leukemia Research (11 papers), Glycosylation and Glycoproteins Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Dita Demirtas is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Glycosylation and Glycoproteins Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Dita Demirtas collaborates with scholars based in Austria, Germany and United States. Dita Demirtas's co-authors include Medhat Shehata, Rainer Hubmann, Martin Hilgarth, Susanne Schnabl, Christoph Zielinski, Josef D. Schwarzmeier, Alexander Gaiger, Peter Valent, Ulrich Jäger and Markus Duechler and has published in prestigious journals such as Blood, Cancer and International Journal of Cancer.

In The Last Decade

Dita Demirtas

15 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dita Demirtas Austria 8 172 82 61 57 50 16 328
Teodora Karan-Djurašević Serbia 12 185 1.1× 76 0.9× 37 0.6× 61 1.1× 37 0.7× 38 360
Shéhérazade Sebda France 9 75 0.4× 76 0.9× 30 0.5× 66 1.2× 36 0.7× 13 313
Martin Kirschner Germany 13 196 1.1× 105 1.3× 87 1.4× 28 0.5× 29 0.6× 33 389
Chi Wai Wong Hong Kong 7 303 1.8× 48 0.6× 130 2.1× 96 1.7× 55 1.1× 12 447
Tammy L. Palenski United States 10 173 1.0× 52 0.6× 73 1.2× 41 0.7× 34 0.7× 20 385
Carla Micucci Italy 9 153 0.9× 39 0.5× 72 1.2× 23 0.4× 60 1.2× 21 422
T. Tataranni Italy 10 116 0.7× 23 0.3× 25 0.4× 39 0.7× 88 1.8× 12 342
Yuichi Konuma Japan 9 184 1.1× 91 1.1× 142 2.3× 32 0.6× 61 1.2× 16 490
Shinya Osone Japan 11 187 1.1× 27 0.3× 76 1.2× 43 0.8× 67 1.3× 37 402
Yunxiao Xu China 13 241 1.4× 56 0.7× 51 0.8× 38 0.7× 47 0.9× 21 387

Countries citing papers authored by Dita Demirtas

Since Specialization
Citations

This map shows the geographic impact of Dita Demirtas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dita Demirtas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dita Demirtas more than expected).

Fields of papers citing papers by Dita Demirtas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dita Demirtas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dita Demirtas. The network helps show where Dita Demirtas may publish in the future.

Co-authorship network of co-authors of Dita Demirtas

This figure shows the co-authorship network connecting the top 25 collaborators of Dita Demirtas. A scholar is included among the top collaborators of Dita Demirtas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dita Demirtas. Dita Demirtas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hubmann, Rainer, Susanne Schnabl, Christian Schmidl, et al.. (2020). Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells. 9(6). 1484–1484. 9 indexed citations
2.
Hubmann, Rainer, Wolfgang Sieghart, Susanne Schnabl, et al.. (2017). Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model. Frontiers in Pharmacology. 8. 319–319. 25 indexed citations
3.
Finsterer, Josef, et al.. (2014). Recurrent takotsubo syndrome in a patient with myotonic dystrophy 1. Acute Cardiac Care. 16(4). 115–117. 4 indexed citations
4.
Hubmann, Rainer, Martin Hilgarth, Susanne Schnabl, et al.. (2012). Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells. British Journal of Haematology. 160(5). 618–629. 31 indexed citations
5.
6.
Hubmann, Rainer, Martin Hilgarth, Susanne Schnabl, et al.. (2011). Inhibition of NOTCH Activity by GLIOTOXIN Induces Apoptosis in CLL Cells and Overcomes the Supportive Effect of Primary Bone Marrow Stromal Cells. Blood. 118(21). 4609–4609. 2 indexed citations
7.
8.
Shehata, Medhat, Rainer Hubmann, Martin Hilgarth, et al.. (2010). Partial Characterization and In Vitro Expansion of Putative CLL Precursor/Stem Cells Which Are Dependent on Bone Marrow Microenvironment for Survival. Blood. 116(21). 2433–2433. 1 indexed citations
9.
Hubmann, Rainer, Markus Düchler, Susanne Schnabl, et al.. (2009). NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells. British Journal of Haematology. 148(6). 868–878. 24 indexed citations
10.
Shehata, Medhat, Susanne Schnabl, Stefanie Tauber, et al.. (2009). Lumiliximab Triggers Apoptosis Mechanisms in CLL Cells through the Inhibition of PI3-K/Akt Pathway.. Blood. 114(22). 2371–2371.
11.
Shehata, Medhat, Susanne Schnabl, Dita Demirtas, et al.. (2008). Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor. Blood. 112(11). 3166–3166. 2 indexed citations
12.
Kainz, Birgit, Medhat Shehata, Martin Bilban, et al.. (2007). Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemia. International Journal of Cancer. 121(9). 1984–1993. 55 indexed citations
13.
Fiegl, Michael, Georg Hopfinger, Stefan Brugger, et al.. (2006). Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia. Cancer. 107(10). 2408–2416. 29 indexed citations
14.
Shehata, Medhat, Josef D. Schwarzmeier, Martin Hilgarth, et al.. (2006). Effect of combined spa-exercise therapy on circulating TGF-β1 levels in patients with ankylosing spondylitis. Wiener klinische Wochenschrift. 118(9-10). 266–272. 51 indexed citations
15.
Hubmann, Rainer, Markus Duechler, Martin Hilgarth, et al.. (2006). Regulation of NOTCH2 Signaling in B-CLL: Involvement of PKC-δ.. Blood. 108(11). 1440–1440. 1 indexed citations
16.
Shehata, Medhat, Susanne Schnabl, Dita Demirtas, et al.. (2005). Interaction between B-CLL Cells and Lymphoid Microenvironment Leads to Activation of PI3-K/Akt Pathway and Inhibition of Apoptosis.. Blood. 106(11). 2102–2102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teodora Karan-Djurašević Breakdown of academic impact, for papers by Shéhérazade Sebda Breakdown of academic impact, for papers by Martin Kirschner Breakdown of academic impact, for papers by Chi Wai Wong Breakdown of academic impact, for papers by Tammy L. Palenski Breakdown of academic impact, for papers by Carla Micucci Breakdown of academic impact, for papers by T. Tataranni Breakdown of academic impact, for papers by Yuichi Konuma Breakdown of academic impact, for papers by Shinya Osone Breakdown of academic impact, for papers by Yunxiao Xu
Rankless by CCL
2026